Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for receptors interleukin- 1
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Most Relevant Literature
- Interleukin-1α, interleukin-1β and interleukin-1 receptor antagonist share a common U-shaped recogni…
- Subfornical organ interleukin 1 receptor: A novel regulator of spontaneous and conditioned fear asso…
- Interleukin-1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease…
- Interleukin-1 receptor inhibition reduces stroke size in a murine model of sickle cell disease.
- Cerebroprotective properties of recombinant interleukin-1 receptor - an experimental study.
Most Relevant Clinical Trials
- BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage
- GDM Patients and Serum Amyloid A and Interleukin-1 (IL-1) Receptor Antagonist
- Effects of Interleukin-1 Receptor Antagonism on Hyperandrogenemia in Women With Polycystic Ovary Syn…
- Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interle…
- Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagon…
